A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver Study

Kumar, Ashish; Panda, Jayant; Agrawal, Prabhat; Gupta, Sunil; Kumar, Dinesh; S. Kuchay, Mohammad; Kesavadev, Jothydev; Mohan, Viswanathan; Jagadeesha, Aravinda; Saboo, Bharat; Tewari, A.; Das, Kunal; Prafull Chandra, Kumar; V. Kulkarni, Shriram; Patil, Shubhashree; Kumar Gupta, Amit; Goswami, Parikshit; Hasnani, Dhruvi; Chavda, Vipul; Agrawal, Mayur; Chhaya, Gaurav; Muralidharan, Chakkarai; Kannan, Aarathy; Rana, Parag; Rastogi, Ashu; Biradar, Sangram; Agasti, Khemeswar; Sankar, Prasanth; Sreenivasa Murthy, L.; Suvarna, Deepak; Kapoor, Rohit; Shah, Kiran; Gupta, Monica; Suri, Sandeep; Srivastava, Anubha; Sanyal, Debmalya; A Bagri, Seema; K. Gupta, Vitull; Sowani, Alpana; Chawla, Purvi; Manish, S.; M. Banthia, Nilesh; Farishta, Faraz; Kapoor, Shivam; Husaini, S.; Sharma, Praveen; Arora, Anil; Misra, Anoop

doi:10.1016/j.lansea.2026.100753

Public

A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver Study

Published in The Lancet Regional Health - Southeast Asia • Mar 26, 2026

Authors:

Ashish Kumar

Jayant Panda

Prabhat Agrawal

Abstract

Background: Type 2 diabetes (T2D) is closely linked to metabolic dysfunction-associated steatotic liver disease (MASLD). However, the burden of clinically significant and advanced liver fibrosis, including cirrhosis, from community-based Indian populations remains poorly defined, with most prior stu...

Subject

Medicine

Type 2 diabetes

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!